| Literature DB >> 35129593 |
Ji-Man Kang1, Jaehun Jung2,3, Young-Eun Kim4, Kyungmin Huh5, Jinwook Hong2, Dong Wook Kim6, Min Young Kim1, Se Yong Jung7, Jong-Hun Kim8, Jong Gyun Ahn1.
Abstract
Importance: Infections are proposed to be triggering factors for Kawasaki disease (KD), although its etiological factors remain unknown. Recent reports have indicated a 4- to 6-week lag between SARS-CoV-2 infection and multisystem inflammatory syndrome in children with a similar presentation to that of KD. Objective: To investigate the temporal correlation between KD and viral infections, focusing on respiratory viruses. Design, Setting, and Participants: This cohort study was conducted among individuals aged 0 to 19 years diagnosed with KD between January 2010 and September 2020 from the Korean National Health Insurance Service. Data on infectious disease outbreaks from 2016 to 2019 were collected from the Korea Disease Control and Prevention Agency, Korean Influenza and Respiratory Virus Monitoring System, Korea Enteroviruses Surveillance System, and the Enteric Pathogens Active Surveillance Network in South Korea. Data were analyzed from December 2020 to October 2021. Main Outcomes and Measures: National databases for infectious diseases were used for a time-series analysis of the correlation between viral infections and KD. The temporal correlation between infectious disease outbreaks and KD outbreaks was evaluated using the Granger causality test (G-test), which is a useful tool to estimate correlations between 2 time series of diseases based on time lags.Entities:
Mesh:
Year: 2022 PMID: 35129593 PMCID: PMC8822386 DOI: 10.1001/jamanetworkopen.2021.47363
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Baseline Characteristics of Individuals With KD
| Characteristics | Individuals, No. (%) (N = 53 424) |
|---|---|
| Sex | |
| Female | 22 510 (42.1) |
| Male | 30 914 (57.9) |
| Age, y | |
| <5 | 44 276 (82.9) |
| 5 to <10 | 8647 (16.2) |
| 10 to <20 | 501 (0.9) |
| Admission year | |
| 2010 | 4934 (9.2) |
| 2011 | 4853 (9.1) |
| 2012 | 4941 (9.2) |
| 2013 | 5469 (10.2) |
| 2014 | 5679 (10.6) |
| 2015 | 5475 (10.2) |
| 2016 | 5255 (9.8) |
| 2017 | 4837 (9.1) |
| 2018 | 5173 (9.7) |
| 2019 | 4690 (8.8) |
| 2020 | 2118 (4.0) |
| IVIG-resistant KD | 9042 (16.9) |
| CAA complication | 384 (0.7) |
| Treatment | |
| IVIG alone | 48 480 (90.7) |
| Corticosteroids | 4944 (9.3) |
| IVIG ≥3 d with corticosteroids | 1859 (3.5) |
| Infliximab | 76 (0.1) |
| Methotrexate | 46 (0.1) |
Abbreviations: CAA, coronary artery abnormality; IVIG, intravenous immunoglobulin; KD, Kawasaki disease.
IVIG-resistant KD was defined as recrudescent or persistent fever 24 to 48 hours after the first IVIG infusion.
Correlation Between the Monthly Incidence of KD and Infectious Disease Outbreaks
| Source | Pearson correlation | ||||
|---|---|---|---|---|---|
| Correlation coefficient, | 1 mo before KD | 2 mo before KD | 3 mo before KD | ||
| KINRESS | |||||
| Overall | 0.7 | <.001 | .02 | .01 | .24 |
| Respiratory syncytial virus | 0.5 | <.001 | .09 | <.001 | .02 |
| Parainfluenza virus | 0.3 | .02 | .24 | .47 | .65 |
| Adenovirus | 0.5 | <.001 | .002 | .01 | .01 |
| Coronavirus | 0.5 | <.001 | .88 | .01 | .02 |
| Metapneumovirus | 0.2 | .23 | .08 | .20 | .35 |
| Rhinovirus | 0.3 | .01 | <.001 | <.001 | <.001 |
| Influenza virus | 0.4 | .004 | .15 | .28 | .37 |
| Bocavirus | 0.3 | .01 | .21 | .26 | .44 |
| EnterNet | |||||
| Rotavirus | 0.2 | .17 | .56 | .53 | .44 |
| Norovirus | 0.5 | <.001 | .56 | .05 | .09 |
| KESS | |||||
| Enterovirus | 0.1 | .47 | .79 | .91 | .48 |
| Notifiable infectious diseases | |||||
| Varicella | 0.7 | <.001 | .01 | <.001 | <.001 |
| Mumps | 0.3 | .01 | .02 | .02 | .03 |
| Scarlet fever | 0.4 | .01 | .08 | .01 | .02 |
Abbreviations: EnterNet, Enteric Pathogens Active Surveillance Network; KESS, Korea Enteroviruses Surveillance System; KINRESS, Korea Influenza and Respiratory Viruses Surveillance System; KD, Kawasaki disease.
The Granger causality test was used to estimate the correlation (precedence) between 2 time series of diseases using time lags.
Figure 1. Monthly Respiratory Viral Infections From the Korea Influenza and Respiratory Viruses Surveillance System
The dotted line represents February 2020, the time point at which nonpharmaceutical interventions for COVID-19 were implemented in South Korea. KD indicates Kawasaki disease.
Figure 2. Monthly Viral Infections From the Korea Enteroviruses Surveillance System and Enteric Pathogens Active Surveillance Network
The dotted line represents February 2020, when nonpharmaceutical interventions for COVID-19 were implemented in South Korea. KD indicates Kawasaki disease.
Figure 3. Monthly Incidence of Notifiable Infectious Diseases
The dotted line represents February 2020, when nonpharmaceutical interventions for COVID-19 were implemented in South Korea. KD indicates Kawasaki disease.